Inaugural Session
Vadodara Pharma Summit 2024, recently organised by Express Pharma focussed on fostering an ecosystem that promotes innovation, excellence, and growth within the pharma industry.
This summit brought together leaders, innovators, and experts from Vadodara's vibrant pharma sector, highlighting the city's critical role as a significant hub for pharma production and research.
It also served as a vital platform for dialogue on pressing topics that shape the future of pharma, ranging from cutting-edge advancements in technology and R&D strategies to navigating complex regulatory landscapes and enhancing sustainability practices.
The Vadodara Pharma Summit also offered ample opportunities for networking and interaction, enabling participants to connect, collaborate, and share valuable experiences.
It commenced with a ceremonial lamp lighting, followed by a welcome address from Express Pharma, setting the stage for a day filled with knowledge exchange and collaboration.
Innovations in active packaging
Active packaging has emerged as a vital aspect in securing the safety and efficacy of medicines. And, as an evolving sphere, it has witnessed several advancements.
Dhairy Sharma, Senior Executive Business Development, Cilicant gave further insights on the role of active packaging. He highlighted the challenges of active packaging such as the possibility of moisture control while retaining the inorganic content.
Cilicant's Accuflip, an equilibrium relative humidity regulator maintains the level of ERH within a specific range to protect the product and prevent the drug from losing its potency. With its line of products, Cilicant aims to aid the pharma industry by providing effective active packaging solutions that eliminate packaging and storage issues of the medicine and ensure its shelf-life, safety and efficacy.
Denne historien er fra November 2024-utgaven av Express Pharma.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra November 2024-utgaven av Express Pharma.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Pharma's strategic path to growth in the nutra maze
The nutraceutical market is a thriving ecosystem of opportunities. For pharma companies, it's a space where the allure of a $11.55 billion pie by 2030 is tempered by a maze of regulatory grey zones, stiff competition, and trust-eroding marketing practices.
PRIME NEO from Gandhi Automations
Gandhi Automation's PRIME NEO High Speed Doors are designed to provide superior sealing and resistance to pressure differences for clean rooms. And the added advantage is that it is absolutely washable
AI smart camera for real-time automation
Integrated asset management functionality and a deep learning tool for training and evaluation keep productivity high and costs low
PROSOLV® 730: Directly compressible carrier for lipophilic ingredients
Nearly 90% of molecules in the discovery pipeline and 40% of drugs with market approval are poorly water soluble.
Complete environmental monitoring solution - testo Saveris Pharma
testo Saveris Pharma monitors and documents temperature, humidity, differential pressure, and other parameters without interruption and compliantly with GxP so that audits and inspections are conducted smoothly
The unmissable Asia healthcare opportunity
BCG's latest report, The Unmissable Asia Healthcare Opportunity, highlights the region's $5 trillion healthcare market potential by 2030, driven by demographic shifts, investment, and innovation.
2025: Healthcare and Lifesciences investment outlook
Kapil Khandelwal, Managing Partner, Toro Finserve and EquNev Capital, interprets the possibilities for the various segments of the Indian lifesciences and healthcare sector for this year
The group's offerings range from over a billion injection doses annually to bespoke medical machinery
Rishad Dadachanji, MD, Dadachanji Group speaks on the company's evolution from a pharma packaging company to a diversified solutions provider in biotechnology, automation, and sterile processing.
DECODING THE M&A LANDSCAPE
Consolidation has emerged as a major trend as the pharma industry seeks new avenues of growth and looks to expand its existing capabilities.
Evolution and commercialisation of cell and gene therapies
Satyen Sanghavi, Founder & CSO, Regrow Biosciences traces the evolution of cell and gene therapies, highlighting global milestones, industry growth, and reimbursement models.
